What is the Real Cost of Developing Medicine?

Healthcare Americana

Panna Sharma, CEO of Lantern Pharma, discusses how his company is bringing cancer therapies to the market faster, cheaper and at a lower cost than other biotechs through artificial intelligence, machine learning and genomic data. He emphasizes that it shouldn’t cost $2 billion to make medicine. He shares it costs this much because Big Pharma is artificially inflating pricing. 

Lantern Pharma is changing healthcare because it is developing new medicines significantly cheaper than big pharma, in a time frame that is unheard of, with only a dozen people.

Support the show (https://healthcareamericana.com/sponsors/)

To listen to explicit episodes, sign in.

Stay up to date with this show

Sign in or sign up to follow shows, save episodes, and get the latest updates.

Select a country or region

Africa, Middle East, and India

Asia Pacific

Europe

Latin America and the Caribbean

The United States and Canada